#EXIT
PANDEMIC
TET RAY
INTERNATIONAL
HEALTH REGULATIONS
Africa Health Security Architecture
A cesspool of Corruption, Conflicts of Interest and Corporate Greed
Africa Health Security Architecture: A cesspool of Corruption, Conflicts of Interest and Corporate Greed
Policy Makers &
Distributors
The International Bank for Reconstruction and Development
Policy Enforcers
African Regulatory Platforms
African Medicines Regulatory Harmonization Initiative |
Africa Vaccine Acquisition Task Team (AVATT) |
Africa Vaccine Acquisition Trust (AVAT) for COVID-19 vaccines |
African Continental Free Trade Area
African Vaccine Regulatory Forum |
South African Enterprises
Kenya |
African Export- Import Bank |
African
Pharmaceutical Technology
Foundation
Corporate Partners
Vaccine Hubs
mRNA Hubs
Senegal
Nigeria
Egypt
African Development Bank
Partnerships for African Vaccine Manufacturing: Conflicts of Interest
https://africacdc.org/download/partnerships-for-african-vaccine-manufacturing-pavm-framework-for-action/
Diseases prioritized by PAVM/FFA Diseases prioritized by WHO
https://africacdc.org/download/partnerships-for-african-vaccine-manufacturing-pavm-framework-for-action/ https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts
African Pharmaceutical Technology Foundation (APTF)
The African Development Bank (AfDB), African Pharmaceutical Technology Foundation (APTF) in association with the African Union, will assist African pharmaceutical companies to scout for technologies and negotiate with global pharma to facilitate the local production vaccines, drugs, diagnostics, and therapeutics.
African Development Bank (AfDB) |
NRA
National Regulatory Authority
Mission
National lot release by WHO-contracted laboratories
To facilitate and speed up vaccine delivery, clinical trial approvals
Regulatory Partnerships
Prequalification of Medicines Programme African Vaccine Regulatory Forum African Medicine Regulatory Harmonisation
International Council for Harmonisation
International Medical Device Regulators Forum
International Clinical Trials Registry Platform
International Narcotics Control Board
Pharmaceutical Inspection Co- operation Scheme
https://www.sahpra.org.za/regulatory-partnership/
VICH
WHO Afro
Marketplace
Africa Innovators
Network
Digital Health Platform for Maternal and Child health through the web, mobile, and mobile social media channels
ALLO SANTE | GIC Space Healthbotics Limited MobiCare | Umubyeyi |
Côte d’Ivoire | Cameroon Nigeria Uganda | Rwanda |
Online Doctor Chat Service
Smartphone Digital Virtual Digital Assistant using Microscopy AI and blockchain technology
for Clinical Documentation
Mobile Based Platform Access and consult doctors
H&S Technologies | Using Data-Driven Uganda Vacc+ DigiMat V-safe After Vaccination Algorithms to Detect DigiTrack Health Checker |
Cameroon | United states of America Uganda Nigeria Centers for Disease Control and Prevention |
Medical equipment using 3D Technology
Identify potentially falsified OpenSRP + RapidPro digital vaccination records for health workers
Calibrated weighing mats automatically transmit vaccine quantities in real time
African Union Smart Safety Surveillance (AU-3S) Programme |
AU-3S programme is a Data Integration and Signal Detection (DISD) system, enabling in-country and cross-country near real- time access, downstream analysis and signal detection. To date, the programme has worked to improve electronic reporting for adverse events following immunization (AEFIs) by incorporating an AEFI form in the Med Safety App launched in 2021.
MedSafety App is available to over 400 million people for AEFI and Adverse Events of Special Interest (AESI) reporting, which has increased safety reporting for vaccines by 8-fold in the AU-3S pilot countries
SAHPRA launched (22 April 2021) the MedSafety App, a WEB- RADR project, a collaboration between the World Health Organisation (WHO), the WHO Collaborating Centre for International Drug Monitoring, the Uppsala Monitoring Centre (UMC), and the UK Medicines and Health products Regulatory Agency (MHRA),
AU-3S programme currently pilots its approach in Ethiopia, Ghana, Kenya, Nigeria and South Africa
Partners
WHO Collaborating Centre for International Drug Monitoring |
African Union Special Envoy on Covid-19
Trevor Manuel
Dr Ngozi Okonjo-Iweala
Dr Donald Kaberuka
Tidjane Thiam
Strive Masiyiwa
Managing Director for Operations (2007 to 2011) |
Development Economist |
Board of Trustees (since 2009) |
WEF/Agenda Contributor |
Young Global Leader |
Board Member |
External Advisory Group |
Member of Finance Committee (2003–2006, 2011–2015) |
Member of the Board |
Director-General |
Senior Advisor (since 2015) |
Chair of the Board |
Board Member |
Special Envoy for Access to COVID-19 Tools (ACT) Accelerator
African Development Bank |
Member of the International Advisory Panel (since 2016) |
Distinguished Fellow
Dr Ngozi Okonjo-Iweala
MEMBER ADVISORY BOARD
MEMBER ADVISORY BOARD |
Minister of Finance Nigeria |
International Commission on Financing Global Education Opportunity
Member of the Board of Directors (since 2018)
Co-Chair
Member
Dr Ngozi Okonjo-Iweala: ‘Global Elitist Hack’
Africa Health Security Architecture |
Chairman AVMI
William Kwabena Ampofo |
Chairman AVMI |
WHO International Health Regulations Steering Committee |
WHO Food and Drugs Authority Technical Advisory Committee on Vaccines and Biologicals |
WHO Global Influenza Programme Technical Advisor |
WHO IHR Emergency Committee on Ebola |
Dr Simon Agwale |
Director AVMI |
CEO of Innovative Biotech |
US Vaccine Research NIH and CDC |
Lead of Bold Program 4 Partnerships for African Vaccine Manufacturing (PAVM) |
Member of The European and Developing Countries Clinical Trials Programme (EDCTP) |
WHO ECOWAS vaccines taskforce |
Patrick Tippoo |
Executive Director AVMI |
Chief Science and Innovation Officer BIOVAC |
Lead, Vaccine Manufacturing Enterprise Working Group within the AU Covid-19 Commission |
Vice-President of the Developing Country Vaccine Manufacturers Network |
Chair of the Emerging Biopharmaceuticals Manufacturing Network (EBPMN) |
Ms Tolu Disu |
Director AVMI |
Vaccines Basic Research with Merck 2009 |
Influence
So
uth
Af
ri
ca
Policy
Makers &
Distributors
The South African Health Architecture
A Cesspool of Corruption, Corporate Greed and Conflicts on Interest
South African Government
The International Bank for Reconstruction and Development
African Union
Policy
Enforcers
South African Regulatory Authorities
Corporate Partners
National Immunisation Safety Expert Committee (NISEC)
South African National Control Laboratory for Biological Products
Academia
Media
University of Cape Town
Updated May 2018
https://apps.who.int/iris/bitstream/handle/10665/136874/ccsbrief_zaf_en.pdf?sequence=1&isAllowed=y
https://apps.who.int/whocc/List.aspx?ksipntDh/RNBv349jCzfvA==
South Africa
SA Academia Collaborating with WHO – A case for Conflicts of Interest
https://health.uct.ac.za/school-public-health/articles/2018-10-04-cider-made-world-health-organization-who-collaborating-centre-hiv-epidemiology-and-research
South African National Control Laboratory for Biological Products |
https://extranet.who.int/pqweb/key-resources/documents/list-who-contracted-laboratories-march-2021
Covid-19:
South African National Control Laboratory for Biological Products Conflicts of Interest
South African National Control Laboratory for Biological Products
Lot Release of Human Vaccines
SANCLBP location Bloemfontein campus, UFS
Member
WHO Collaborating Centre for Vaccine Preventable Diseases Surveillance and Pathogens Genomics |
WHO-National Control Laboratory Network for Biologicals |
https://www.sahpra.org.za/wp-content/uploads/2021/10/2.66_Guideline-for-Lot-Release-of-Human-Vaccine-_V1-2021.pdf
WHO Collaborating Centre for HIV Epidemiology and Research |
Regional reference laboratory for the World Health Organization (WHO) Vaccine- preventable Invasive Bacterial Diseases (VP-IBD) Coordinated Global Surveillance Network for the Southern African region
WHO-AFRO Regional Center of Excellence Bioinformatics | ||
SA Academia Collaborating with WHO – A case for Conflicts of Interest
A (SA) national response to antimicrobial resistance is required to complement the development of a global action plan, as articulated in the World Health Organisation’s (WHO) resolution EB134/37 “Combating antimicrobial resistance including antibiotic resistance”, adopted by the World Health Assembly in May 2014.
https://cdn.who.int/media/docs/default-source/antimicrobial-resistance/amr-spc-npm/nap-library/south-africa-antimicrobial-resistance-national-action-plan-2018---2024.pdf?sfvrsn=533118b0_1
Intergovernmental Negotiating Body (INB)
Conflicts of Interest
Intergovernmental Negotiating Body
Ms Precious Matsoso
(South Africa)
* Member of the Executive Board of World Health Organisation
* Director General of the National Department of Health, SA
Dr Roland Driece
(Netherlands)
Co-Chairs of
Intergovernmental
Negotiating Body
(INB)
(February 24, 2022)
The INB was established to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response focused on a new revised International Health Regulations
https://pandorareport.org/2020/05/29/pandora-report-5-29-2020/
* Chair of the Global Health Security Agenda
* Vice-President, Conference of the Parties representing the European Region
Dr Precious Matsoso – “Global Elitist Hack” - Conflicts of Interest
Former Vice-chair and Chairperson |
WHO Executive Board Member |
Chairperson |
Independent Oversight and Advisory Committee |
Member |
Emergencies Programme |
Member |
Chair |
Ministerial Advisory Committee on e-Health |
Chair |
Policy Review Committee |
Co-Chair |
Digital Health Technical Advisory Group |
Member | |
Member
Dr Precious Matsoso |
Member |
Director |
Technical Cooperation for Essential Medicines and Traditional Medicines |
Director |
Public Health Innovation and Intellectual Property |
Honorary Lecturer
Department of Pharmacy & Pharmacology
Former Registrar |
Medicines of the National Drug Regulatory Authority |
Director-General |
Chair of Technical National Health Council |
Vice-Chair |
Anti-Microbial Resistance Committee |
Member |
Commission on High Quality Health Systems |
Member Board |
Member |
Health Regulatory Science Platform |
Author | |
Board of Directors |
Author |
Author |
Member Advisory Group |
UN High-Level Panel on Access to Health Technologies
“It will require goodwill and commitment from countries. Where countries don’t commit, we will have to use other measures. We might look at whether we want to impose sanctions on thosecountries or come up with incentives”
Dr Precious Motsoso
Co-Chair at the WHO Pandemic Prevention Preparedness and Response
https://www.theeastafrican.co.ke/tea/news/east-africa/afdb-pushes-for-access-to-pharma-technology-4058144
https://twitter.com/DrTedros/status/1622891989443248129
Recipients of mRNA technology from the WHO mRNA technology transfer hub
https://medicinespatentpool.org/news-publications-post/who-and-mpp-announce-names-of-15-manufactures-to-receive-training-from-mrna-technology-transfer-hub
mRNA Technology Transfer Hub Funders A Case for Conflicts of Interest
supports the mRNA Technology Transfer Hub Programme for the production of mRNA vaccines
Steering Committee members (July 2022) - comprising of experts in mRNA vaccine development
Marion Gruber |
Vice President International AIDS Vaccine Initiative (IAVI) |
Director, U.S. Food and Drug Administration (FDA) Office of Vaccine Research and Review (1992 to 2021) |
FDA, Overseeing licensure and approval for COVID-19 vaccines |
Expert Advisor to WHO |
Member, WHO Global Advisory Committee on Vaccine Safety |
Mark Feinberg | |
President and CEO of IAVI | Establishment The MSD- Wellcome Trust Hilleman Laboratories |
Medical Officer, Office of AIDS Research at NIH | |
Chief Public Health and Science Officer, Merck Vaccines | Fellow in the Advanced Leadership Initiative at Harvard University |
Member of the CEPI Joint Coordinating Group | Member, Council on Foreign Relations |
Chair of Interim Scientific Advisory Committee, Collaboration for Epidemic Preparedness Innovations (CEPI) | |
Acting Head, Clinical Development, for the Coalition of Epidemic Preparedness Innovations (CEPI) | |
Global Clinical Research and Development teams at both Sanofi Pasteur and GlaxoSmithKline Biologicals | |
Marie-Paule Kieny | |||
Chairs Board of Medicines Patent Pool Foundation | Assistant Director-General for Health Systems and Innovation at the WHO 2017 | ||
Chair Board, Drugs for Neglected Diseases Initiative (DNDi) | |||
Vaccine Research Director WHO (2002 – 2010) | |||
Wellcome Trust, Chair of the Strategic Advisory Board on Vaccines and Drug-resistant Infections | Non-Executive Independent Director of BioMérieux | ||
Chair French Scientific Committee on COVID-19 vaccine | |||
Board of Directors for the Human Vaccines Project | |||
Advisor GISAID (Global Initiative on Sharing Avian Influenza Data) for the COVID-19 pandemic | |||
Member of European Vaccine Initiative till 2010 | |||
Global Antibiotic Research and Development Partnership (GARDP), Member of the Board of Directors | |||
Mmboneni Muofhe
Michel de Wilde
Independent vaccine R&D vaccine expert
Deputy Director-General, Department of Science and Innovation (DSI), South Africa
Led the development of drugs and vaccine
Senior Vice President, R&D, Sanofi Pasteur (2001 – 2013)
https://medicinespatentpool.org/covid-19/mrna-technology-transfer-hub-programme/governance#Steering-Committee/
Nadia Tornieporth
Professor of Clinical Research and Pharmacovigilance
Research Scientist, recombinant Hepatitis B vaccine, and GSK’s Malaria vaccine candidate
Nicaise Ndembi
Senior Science Advisor, Africa CDC
The mRNA Scientific Advisory Committee (mSAC) - comprising of experts in mRNA vaccine development
| ||
Former Deputy Director of the NIAID Vaccine Research Center | ||
Chief of the Viral Pathogenesis Laboratory, NIH | ||
Viral Pathogenesis Laboratory, NIH partner with Moderna to develop Covid-19 vaccine |
Martin Friede |
mSAC Chair |
Coordinator, Initiative for Vaccine Research at the WHO |
Vice President of Vaccine Development for Apovia Inc |
Lead vaccine delivery research at Smithkline Beecham Biologicals |
| ||
R3 Program Director at Wellcome Leap (Wellcome Trust and CEPI) | ||
Senior Director, GSK – Vaccine R&D | ||
Director, Novartis Vaccines, Vaccines R&D |
Suhaib Siddiqui |
Former Director, Chemistry, Moderna Therapeutics Inc |
Founder of Antirna Inc |
Vice President Technology |
Director of Chemistry Helicos BioSciences |
Research Fellow National Institutes of Health |
Danilo Casimiro | |
Chief Science Officer & Global Head, External Scientific Affairs, Sanofi Vaccines | Chief Scientific Officer, Aeras (2017) funded by the Bill and Melinda Gates Foundation |
Lead Vaccine R&D, Merck Research Laboratories | Scientific Advisor Bill & Melinda Gates Foundation Global Health Program |
Scientific Advisor USAID Malaria Vaccine Development Program | Scientific Advisor International AIDS Vaccine Initiative |
Scientific Advisor HIV Vaccine Enterprise | Scientific Advisor NIH AIDS Vaccine Development Program |
Kiat Ruxrungtham
Scientific Chair of the Chula Vaccine Research Center (ChulaVRC)
Director of the Covid19 Vaccine Development Program, ChulaVRC
Lead Chula-Covid19 mRNA vaccine development program
https://medicinespatentpool.org/covid-19/mrna-technology-transfer-hub-programme/governance#mSAC--mRNA-Scientific-Advisory-Committee
supports the mRNA Technology Transfer Hub Programme for the production of mRNA vaccines
mRNA Technology Transfer Hub Funders A Case for Conflicts of Interest
WHO, Gates Foundation and South Africa join forces on Covid Vaccines
The programme focus; mRNA vaccines against COVID-19. Further development of other mRNA vaccines and therapeutics against important diseases that threaten LMICs.
The Medicines Patent Pool (MPP) and the World Health Organization (WHO), Afrigen Biologics (PTY) Limited, the Biologicals and Vaccines Institute of Southern Africa (Biovac), the South African Medical Research Council (SAMRC) and Africa Centres for Disease Control and Prevention (Africa CDC) have signed a letter of intent to address the global imbalance of manufacturing capacity for COVID-19 vaccines.
https://www.who.int/news/item/30-07-2021-new-consortium-working-to-boost-vaccine-production-in-south-africa
WHO, Gates Foundation and South Africa join forces on Covid Vaccines
https://cdn.who.int/media/docs/default-source/2021-dha-docs/press-release-letter-of-intent-30-july-2021.pdf?sfvrsn=7906619c_5
“...to build capacity in low- and middle-income countries to produce mRNA vaccines through a centre of excellence and training (the mRNA vaccine technology hub). The hub is located at AFRIGEN, Cape Town, South Africa.”
https://www.who.int/initiatives/the-mrna-vaccine-technology-transfer-hub
mRNA Technology Transfer Hub Partners: A Case for Conflicts of Interest
https://www.gov.za/speeches/world-health-organization%E2%80%99s-director-general-dr-tedros-adhanom-ghebreyesus-visits-mrna
mRNA Technology Transfer Hub Partners: A Case for Conflicts of Interest
https://medicinespatentpool.org/covid-19/mrna-technology-transfer-hub-programme
WHO, Gates Foundation and South Africa join forces on Covid Vaccines
Partnerships
The South African Ministerial Advisory Committee on COVID-19, WHO and Gates Foundation Conflicts of Interest
Researcher
Prof Salim Abdool Karim
Prof Quraisha Abdool Karim
Prof Helen Rees
Prof Wolfgang Preiser
Prof Lucille Blumberg
Prof Shabir Madhi
Prof Glenda Gray
Prof Marc Mendelson
Prof Francois Venter
Prof Shabir Banoo
Institution
CAPRISA
Role in MAC
Role in WHO
Principal Funder
The Centre for AIDS Programme of Research in South Africa (CAPRISA)
OVER-ARCHING CHAIR
WHO Science Panel WHO TB-HIV task force
Bill and Melinda Gates Foundation (BMGF)
Public Health
Deputy-Chair, WHO Alliance for Sexual and Reproductive Health
BMGF
Chairperson, South African Health Products Regulatory Authority
National Health Laboratory Service
Wits Health Consortium
Clinicians
WHO IHR Emergency Committee for COVID-19
BMGF
Pathologists and Laboratory
Member of a WHO SARS mission to China
BMGF
National Institute Communicable Diseases (NICD)
Clinicians
Committee for Review of the International Health Regulations during COVID-19
BMGF
CHAIR, Public Health
WHO, Strategic Advisory Group of Experts on Immunization, Vaccines and Biologicals (SAGE)
BMGF, Scientific Advisor
South African Medical Research Council (SAMRC) President
University of Cape Town
CHAIR, Research
National Institute for Health, Wellcome Trust
BMGF
CHAIR, Clinicians
WHO Expert Panel on Drug Evaluation
BMGF
University of KwaZulu-Natal
Right to Care
Clinicians
Clinicians
WHO Advisor
WHO Technical Consultant
BMGF
BMGF
Director and Co-Founder |
Member Steering Committee |
Member Scientific Advisory Committee |
Fellow of the Royal Society (FRS) |
Over-Arching Chair | |
South African Ministerial Advisory Committee on COVID-19 |
Member Steering Committee | |
Africa Task Force For Coronavirus |
Board Member |
Pro-Vice-Chancellor |
Prof Salim Abdool Karim |
Scientific Advisor |
Adjunct Professor | |
Member |
Trustee |
Former President and CEO |
Chair: Grant Review Committee |
DoD Medical Research and Development Program |
Fellow |
Chair: Scientific Expert Panel |
Masters Student, 1988 |
Professor
Editorial Board |
Advisor |
- WHO Science Council - Scientific Advisor to WHO Director-General
|
Associate |
Scientific Advisory Committee |
Editorial Board |
Scholarship1987 |
Consultant |
Editorial Board |
Commissioner |
Member |
Masters Scholarship, 1987 |
Interim Director |
MRC HIV-TB Pathogenesis and Treatment Unit |
Director |
Chair: Program Human Reproduction
Co-Chair AIDS Research
Prof Salim Abdool Karim: A ‘Global Élite’ Puppet
Advisor of Global Health
Vice-President
Karim gets his reward?
Prof Helen ReesChairperson
Prof Helen Rees: WHO and ‘Global Elite’ Vaccine Hack
Strategic and Technical Advisory Group on Infectious Hazards with Pandemic and Epidemic Potential (STAG-IH) |
Member |
WHO Scientific and Technical Advisory Group on Infectious Hazards |
Advisor |
Technical Advisory Committee on RSV Vaccines |
Advisor |
WHO Africa Regional Reproductive Health Task Force |
Member |
WHO IHR Emergency Committee for COVID-19
International Health Regulation Emergency Committee on COVID-19
Member
Chair
IHR Emergency Committee on Polio
International Health Regulations Review Committee
IHR Emergency Committee on Yellow Fever
Member
SAGE focal point for HPV, Rubella, and HIV vaccines, and vaccine use in humanitarian emergencies Committee |
Member |
Rapporteur |
Review Committee on the Role of the IHR (2005) in the Ebola Outbreak and Response |
Member (2015 to 2016) |
African Regional Immunisation Technical Advisory Group on Immunization (RITAG) |
Chair |
SAGE Committee on the Global Vaccine Action Plan |
Member/Advisor |
SAGE Committee evaluating progress towards the Decade of Vaccines |
Member |
SAGE Working Group on Measles and Rubella |
Member |
SAGE Working Group on Ebola Vaccines |
Chair |
Prof Helen Rees, OBE
Chair (since 2014)
Polio Research Group
Member
TFI Working group on Ebola
Chair
WHO RSV Vaccine Consultation Expert Group
WHO Global Strategic Advisory Group of Experts on Immunisation (SAGE) |
Chair |
Wits RHI – WHO/UNAIDS Collaborating Centre in Reproductive Health and HIV |
Lead Advisor |
Advisor
SAGE Committee on Ebola vaccines |
Co-Chair |
WHO Regional Vaccine
PATH Maternal Influenza Immunisation Committee |
Chair Advisory Review Committee |
WHO/UNAIDS Steering Committee on Pre-exposure prophylaxis |
Advisor |
Advisory Chairperson
High Level Meeting on Ebola vaccines |
Chair |
STI vaccine development and strategy Committee
Advisor
Wits Reproductive Health and HIV Institute and Prof Helen Rees
Conflicts of Interest
Donors & Partners
Founder & Director of Wits RHI
https://www.wrhi.ac.za/about/partners-donors
Prof Shabir A. Mahdi: A ‘Global Élite’ Puppet – Positions Held
Working group: Influenza vaccination of health workers |
Product and Development Vaccine Advisory Committee |
Chair: Consultation on GBS Vaccine Development |
Chair: Eighth WHO meeting on development of influenza vaccines |
Strategic Advisory Group of Experts (Vaccines) |
RSV Vaccine Consultation Expert Group |
Strategic Advisory group Group B streptococcus value proposition |
Member Scientific Advisory Committee |
Scientific Advisory Committee (2016 to date) |
Scientific Advisory Committee |
Member |
South African ChAdOx1Cov-19 Vaccine Trial |
Principal Investigator |
Over-Arching Chair | |
South African Ministerial Advisory Committee on COVID-19 |
COVID Vaccine Trial Group |
Founder & Executive Director |
2008 to date |
DST/NRF South African Research Vaccine Preventable Diseases Unit |
Chair |
Partners
2013 to 2020
Director: MRC Vaccines and Infectious Diseases Analytics Research Unit
Director: MRC Respiratory and Meningeal Pathogens Research Unit
Chairman and Non-Executive Director |
Principal investigator |
Director Vaccines and Infectious Diseases Analytical Research Unit |
2020 to present |
Professor of Vaccinology |
Chair National Advisory Group for Immunization South Africa |
Wits African Leadership in Vaccinology Expertise | |
Co-director (2017 to present) | |
Partners
Prof Shabir A. Mahdi,
Phase 2 NVX-CoV2373 Vaccine Trial
Executive Director (2011 to 2017)
Acting Chief Executive Officer
Principal Investigator
Member (2016 to present)
SA
Global Pneumonia Prevention Coalition
Scientific Advisory Group
Prof Shabir A. Mahdi: Principal Vaccinologist - Funding
Trial Grant $15 million
Publication Funding
Funder
Funder
Funder
Funder
Grant Funding
Grant Funding
Grant Funding
Grant Funding
F U N D E R
Committed Grants |
Honoraria for Advisory Board Participation |
$750million |
Grant ZAR 3,856,600 |
Consultant/Speaker Fees |
Publication Funding |
Prof Shabir A. Mahdi Prof of Vaccinology, Univ. of Witwatersrand
Scientific Advisor |
Honoraria payment |
Publication Funding |
$1.4m $1.3m $250,000 |
Grant Funding |
European and Developing Countries Clinical Trials Partnership
$3 million |
Grant Funding |
Future Fund |
R8 million |
$300 000 $59 493 |
Grant Funding |
Trial Grant $2,118,618.51 |
Grant Funding |
FUNDER |
ZAR 2.5m |USD 5.8m |
Scientific Advisor |
Consultant/Speaker Fees |
Honoraria payment |
Publication Funding |
Scientific Advisor |
Honoraria payment |
Publication Funding |
Grant ZAR 3,856,600 |
Consultant/Speaker Fees |
Publication Funding |
Grant Funding |
Grant Funding |
Consultancy Fees |
$2 million |
Grant Funding |
Grant Funding |
Product Development for Vaccines Advisory Committee
Strategic Advisory Group of Experts on Immunization, Vaccines and Biologicals (SAGE)
Bernard Fritzell, M.D., M.P.H former Vice- President, International Scientific and Clinical Affairs, Pfizer Vaccines Research
Barney S. Graham, M.D., PhD Senior Investigator at the Vaccine Research Center, NIAID, NIH
Ruth Karron, M.D. CDC Advisory Committee on Immunization Practices. FDA Vaccine and Related Biological Products Advisory Committee
David C. Kaslow, M.D Vice President, Essential Medicines, and Head, PATH’s Center for Vaccine Innovation and AccessVice President and Head of Vaccines Project Leadership and Management at Merck Research Laboratorie National Institute of Allergy and Infectious Diseases (NIAID)
Jerome H. Kim, M.D., Director General of the International Vaccine Institute (IVI) funded by Bill and Melinda Gates Foundation.
Prof. Shabir Madhi, Prof Vaccinology, Wits Univ. Head of SA AstraZeneca ChAdOx1 Trial, Chair of the National Advisory Group for Immunization in South Africa and on the Scientific Advisory Committee of the Bill and Melinda Gates Foundation Global Health Program.
National Institute for Communicable Diseases, SA Conflicts of Interest
Deputy Director
National Institute for Communicable Diseases
Prof Lucille Blumberg
Vice-Chair, WHO Committee for Review of the International Health Regulations during COVID-19
https://icon.indushospital.org.pk/speaker/professor-lucille-blumberg/
Conflicts of Interest
National Influenza Centre (NIC); and a WHO RSV and SARS-CoV-2 Reference Laboratory
Regional reference laboratory for the World Health Organization (WHO) Vaccine- preventable Invasive Bacterial Diseases (VP- IBD) Coordinated Global Surveillance Network for the Southern African region
trial
Principal Investigator
Dr Francois Venter
: Dr Francois Venter
Sponsors | |
INTEREST 2015 Conference | |
Presenter | |
Funding Agencies
Wits Reproductive Health and HIV Institute
COHIVE: Coronavirus Outcomes in HIV Evaluation
ADVANCE Trial US$ 22,851,279
Funder
Funder
Funder
Funder Funder
Funder
Personal Fees/Support
Research Funding
New Partnership for Africa’s Development Planning and Coordinating Agency
Director
ACTaccelerator ACCESS TO COVID-19 TOOLS
Advisor
Advisor Funder
Advisor
The STAR Initiative consortium | ||
Advisor/Funder | ||
Funder
Prof Marc Mendelson: “Global Elite Puppet”
Global Challenges Research Fund |
Funder |
Funder
Prof Marc Mendelson
Head of the Division of Infectious Diseases & HIV Medicine at Groote Schuur Hospital
Partners
Partners
Funder
Scientific Advisory Board Member 2016 - 2022
Bill Gates, Co-Chair and Trustee
Antimicrobial Resistance Benchmark |
Member of the Expert Committee 2020 |
Funder
Centre for Infectious Disease
Research and Policy Antimicrobial Stewardship Project
ASP Advisory Committee
WHO Policy Guidance on Integrated Antimicrobial Stewardship
Expert Panel on Drug Evaluation
Member (2017 to 2025)
Antibiotic Working Group
Member (2017 to 2022)
Multiple Technical Advisory Groups on Antimicrobial Resistance)
Core Team on Tackling Antimicrobial Resistance
Participant (Dec 2020)
Member (2012 – 2022)
Funder
No comments:
Post a Comment